Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PCPC Hatching Proposal For CIR Role In FDA Ingredient Review

Mar 08 2017

• By Lauren Nardella

Related Content

Cosmetic Ingredient Use Under Feinstein Bill; Where Does CIR Come In?

Apr 22 2015

Cosmetics Stakeholders Race To Hitch Reform Provisions To FDA User-Fee Bills

Mar 03 2017

House Cosmetics Bill Reintroduced; ICMAD Optimistic In New Political Climate

Jan 13 2017

PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises

Jan 23 2017

FDA Questions Constitutionality Of Proposed CIR Bridge, A Blow To CMA Bill

Nov 04 2016

Additional Topics

United States Legislation Cosmetics Ingredients FDA Safety Consumer

More from Legislation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window